ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
About this study
The purpose of this research is to see how personal financial burden (financial toxicity) related to cancer affects the overall health and quality of life by evaluating the impact of systematic financial navigation in addition to standard financial distress interventions during cancer treatment.
- Condition
- Acute Myeloid Leukemia
- Tested
- Arm A, Arm B
- Sponsor
- Wake Forest University Health Sciences
Who can join
- Age
- 18 to 64 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 9
- Minimum age: 18 years
- Maximum age: 64 years
- Study condition: Acute Myeloid Leukemia
- Ability to understand and willingness to sign an IRB-approved informed consent.
- Age 18-64 years at the time of consent
- Initial diagnosis of Acute Myeloid Leukemia (AML) per investigator Note: Date of initial diagnosis is the date of the bone marrow biopsy
- Planned intensive induction chemotherapy Note: It is acceptable if chemotherapy has been initiated at the time of enrollment as long as it is within 30 days of therapy initiation
- Ability to read and understand the English and/or Spanish language(s)
- As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.
Exclusion 4
- Diagnosis of Acute Promyelocytic Leukemia
- Unwilling to receive induction chemotherapy for AML
- Previous treatment for hematologic malignancy
- Prior allogeneic hematopoietic stem cell transplant
Where
2 sites, 2 recruiting
Levine Cancer Insitute
Charlotte, North Carolina, United States
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Contact
-
Courtney Schepel
(980) 442-2327 Courtney.Schepel@advocatehealth.org
-
Thomas Knight, MD
(980) 442-4363 Thomas.Knight@advocatehealth.org
Potential match only. Final eligibility is determined by the study team.